Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (311-320 of 441) with videos related to

Pageof 45
Sort By:
Annals of Surgical Oncology|July 4, 2003
Chest wall recurrence after mastectomy does not always portend a dismal outcomeAnees Chagpar, Funda Meric-Bernstam, Kelly K Hunt, et al.
The Oncologist|May 6, 2021
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3Hiroji Iwata, Yoshiko Umeyama, Yuan Liu, et al.
The Breast Journal|August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKaren A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|September 2, 2021
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and ChinaXiaoran Liu, Andrew A Davis, Feng Xie, et al.
Cancer|June 22, 2005
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrenceJeannie Shen, Kelly K Hunt, Nadeem Q Mirza, et al.
Breast Cancer Research and Treatment|April 10, 2013
Genomic and expression analysis of microdissected inflammatory breast cancerWendy A Woodward, Savitri Krishnamurthy, Hideko Yamauchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2015
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasisShin-Ae Kang, Nafis Hasan, Aman P Mann, et al.
International Journal of Molecular Sciences|August 27, 2021
Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)Yulan Gong, Rajeswari Nagarathinam, Maria F Arisi, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Pageof 45

Showing results (311-320 of 441) with videos related to

Sort By:
Pageof 45
Annals of Surgical Oncology|July 4, 2003
Chest wall recurrence after mastectomy does not always portend a dismal outcomeAnees Chagpar, Funda Meric-Bernstam, Kelly K Hunt, et al.
The Oncologist|May 6, 2021
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3Hiroji Iwata, Yoshiko Umeyama, Yuan Liu, et al.
The Breast Journal|August 27, 2019
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKaren A Gelmon, Massimo Cristofanilli, Hope S Rugo, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|September 2, 2021
Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and ChinaXiaoran Liu, Andrew A Davis, Feng Xie, et al.
Cancer|June 22, 2005
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrenceJeannie Shen, Kelly K Hunt, Nadeem Q Mirza, et al.
Breast Cancer Research and Treatment|April 10, 2013
Genomic and expression analysis of microdissected inflammatory breast cancerWendy A Woodward, Savitri Krishnamurthy, Hideko Yamauchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2015
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasisShin-Ae Kang, Nafis Hasan, Aman P Mann, et al.
International Journal of Molecular Sciences|August 27, 2021
Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)Yulan Gong, Rajeswari Nagarathinam, Maria F Arisi, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Pageof 45